South African Biotech Startup Immobazyme Closes Funding Round, Reaches R24.5 Million
Stellenbosch-based biotechnology startup Immobazyme has successfully closed its latest funding round, bringing its total investment to R24.5 million. This new capital injection will allow the company to expand its facilities and enhance its production capabilities.